Guangzhou Kingmed Diagnostics Group Co Ltd
SSE:603882

Watchlist Manager
Guangzhou Kingmed Diagnostics Group Co Ltd Logo
Guangzhou Kingmed Diagnostics Group Co Ltd
SSE:603882
Watchlist
Price: 28.99 CNY -1.6% Market Closed
Market Cap: 13.4B CNY
Have any thoughts about
Guangzhou Kingmed Diagnostics Group Co Ltd?
Write Note
Guangzhou Kingmed Diagnostics Group Co Ltd
/
Cash Flow Statement
/
Cash Paid for Dividends

Guangzhou Kingmed Diagnostics Group Co Ltd
Cash Paid for Dividends

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Guangzhou Kingmed Diagnostics Group Co Ltd
Cash Paid for Dividends Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Paid for Dividends CAGR 3Y CAGR 5Y CAGR 10Y
Guangzhou Kingmed Diagnostics Group Co Ltd
SSE:603882
Cash Paid for Dividends
-¥417.8m
CAGR 3-Years
-35%
CAGR 5-Years
-52%
CAGR 10-Years
N/A
Jinxin Fertility Group Ltd
HKEX:1951
Cash Paid for Dividends
-¥10.5m
CAGR 3-Years
59%
CAGR 5-Years
50%
CAGR 10-Years
N/A
Topchoice Medical Co Inc
SSE:600763
Cash Paid for Dividends
-¥151m
CAGR 3-Years
-107%
CAGR 5-Years
-44%
CAGR 10-Years
N/A
Nanjing Xinjiekou Department Store Co Ltd
SSE:600682
Cash Paid for Dividends
-¥49.8m
CAGR 3-Years
21%
CAGR 5-Years
16%
CAGR 10-Years
11%
Dian Diagnostics Group Co Ltd
SZSE:300244
Cash Paid for Dividends
-¥588.8m
CAGR 3-Years
-34%
CAGR 5-Years
-21%
CAGR 10-Years
-34%
Meinian Onehealth Healthcare Holdings Co Ltd
SZSE:002044
Cash Paid for Dividends
-¥202.5m
CAGR 3-Years
10%
CAGR 5-Years
19%
CAGR 10-Years
-34%
No Stocks Found

Guangzhou Kingmed Diagnostics Group Co Ltd
Glance View

Market Cap
13.6B CNY
Industry
Health Care

Guangzhou Kingmed Diagnostics Group Co Ltd has crafted its journey in the healthcare industry with precision and analytical prowess. Emerging in the early 2000s, Kingmed Diagnostics tapped into a burgeoning market niche—offering diagnostic testing services to hospitals, clinics, and other medical institutions. With a blend of advanced technology and extensive scientific expertise, the company provides a range of services, from routine clinical testing to esoteric evaluations that require more sophisticated techniques. Kingmed’s laboratories, strategically established across China, facilitate a seamless operation that processes millions of tests annually, ensuring timely and accurate results. This operational efficiency not only supports healthcare providers in delivering informed patient care but also positions Kingmed at the forefront of diagnostic innovation. Revenue streams flow through service contracts with healthcare facilities and direct partnerships where they provide specialized testing offerings that institutions may not have the infrastructure to perform in-house. By leveraging economies of scale, Kingmed achieves cost efficiencies, which in turn afford competitive pricing structures, further securing its market position. Complementing its robust diagnostic services, the company also invests in research and development initiatives, continuously enhancing its test portfolio. This commitment to innovation ensures that they stay relevant in the ever-evolving healthcare landscape, capturing new opportunities and expanding their market reach. Through this strategic framework, Guangzhou Kingmed Diagnostics not only sustains its financial growth but also fortifies its leadership in the diagnostic services sector.

Intrinsic Value
46.73 CNY
Undervaluation 38%
Intrinsic Value
Price
What is Intrinsic Value?

See Also

What is Guangzhou Kingmed Diagnostics Group Co Ltd's Cash Paid for Dividends?
Cash Paid for Dividends
-417.8m CNY

Based on the financial report for Sep 30, 2024, Guangzhou Kingmed Diagnostics Group Co Ltd's Cash Paid for Dividends amounts to -417.8m CNY.

What is Guangzhou Kingmed Diagnostics Group Co Ltd's Cash Paid for Dividends growth rate?
Cash Paid for Dividends CAGR 5Y
-52%

Over the last year, the Cash Paid for Dividends growth was 50%. The average annual Cash Paid for Dividends growth rates for Guangzhou Kingmed Diagnostics Group Co Ltd have been -35% over the past three years , -52% over the past five years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 211,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.